United States Securities and Exchange Commission v. Reven Holdings, Inc. et al

1:22-cv-03181

May 14, 2025
10th Circ. Chilly To Biotech's SEC Asset Freeze Challenge

A panel of Tenth Circuit judges seemed skeptical Wednesday that a lower court had abused its discretion in granting a freeze of a biotech firm's assets in a suit brought by the U.S. Securities and Exchange Commission accusing the company and its founders of misappropriating roughly $9 million.
August 07, 2024
Biotech Firm Can't Pause SEC Action During Appeal

A Colorado federal magistrate judge won't pause a lawsuit by securities regulators against a biotech company accused of misappropriating roughly $9 million while the company appeals an asset freeze, agreeing in a Wednesday order with the SEC's argument that investors would be better served if the case moved ahead.
March 29, 2024
SEC Wins Extended Asset Freeze Against Biotech Co.

A Colorado federal judge on Friday granted the U.S. Securities and Exchange Commission's request to make permanent a restraining order freezing a biotech company's assets while the case proceeds, finding that the regulator is likely to prevail in the suit.
June 13, 2023
Biotech Co. Says SEC Can't Back Up Asset Freeze

A biotech startup is urging a Colorado federal judge to reject the U.S. Securities and Exchange Commission's bid to extend a freeze on its assets, arguing regulators relied on bad information to claim its executives misappropriated $8.8 million in investor funds.